Detalhe da pesquisa
1.
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey.
Support Care Cancer
; 29(11): 6903-6912, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023950
2.
Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action.
Curr Oncol
; 31(3): 1460-1469, 2024 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534943
3.
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.
Curr Oncol
; 31(5): 2453-2480, 2024 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785465
4.
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.
Curr Oncol
; 31(4): 1803-1816, 2024 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668039
5.
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.
Oncologist
; 18(7): 812-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23814044
6.
Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895".
Curr Oncol
; 30(5): 5050-5053, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232839
7.
HR+/HER2- Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review.
Curr Oncol
; 30(6): 5425-5447, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366894
8.
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm.
Ther Adv Med Oncol
; 15: 17588359231175440, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37323186
9.
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
Dermatol Ther (Heidelb)
; 13(4): 867-889, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929121
10.
Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021.
Curr Oncol
; 29(3): 1919-1931, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323356
11.
Access Denied? The Unintended Consequences of Pending Drug Pricing Rules.
Curr Oncol
; 29(4): 2504-2508, 2022 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35448178
12.
Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
Curr Oncol
; 29(12): 9891-9895, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547192
13.
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic.
Curr Oncol
; 28(2): 1338-1347, 2021 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33805031
14.
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation.
J Bone Oncol
; 27: 100351, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33680749
15.
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Can Urol Assoc J
; 14(4): E137-E149, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702544
16.
Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial.
J Eval Clin Pract
; 25(2): 196-204, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672056
17.
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
Dermatol Ther (Heidelb)
; 13(8): 1889-1890, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410207
18.
Sunitinib toxicity management - a practical approach.
Can Urol Assoc J
; 10(11-12Suppl7): S248-S251, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096938
19.
Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care system.
J Thorac Oncol
; 8(9): 1136-41, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887170
20.
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.
J Clin Oncol
; 29(29): 3877-84, 2011 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21911726